Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast

Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq: CODX) will release its second quarter 2021 financial results on August 12, 2021, after market close. The company aims to discuss these results in a conference call at 4:30 p.m. EDT on the same day, featuring CEO Dwight Egan and CFO Brian Brown. Co-Diagnostics focuses on molecular diagnostics with a patented technology for developing diagnostic tests based on nucleic acid detection. The results and call are crucial for investors seeking insights into the company's financial performance and future outlook.

SALT LAKE CITY, Aug. 4, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its second quarter 2021 results on Thursday, August 12, 2021, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. EDT to discuss its financial results with analysts and institutional investors.  Management on the call will include CEO Dwight Egan and CFO Brian Brown.

The call and webcast will be available via:

Webcast:	ir.codiagnostics.com on the Events & Webcasts page
Conference Call:	877-317-6789 (domestic) or 412-317-6789 (international)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures, and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-second-quarter-2021-earnings-release-date-and-webcast-301348453.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics release its second quarter 2021 earnings?

Co-Diagnostics will release its second quarter 2021 earnings on August 12, 2021, after market close.

What time is the Co-Diagnostics conference call for the second quarter earnings?

The conference call for Co-Diagnostics' second quarter earnings will take place at 4:30 p.m. EDT on August 12, 2021.

Who will be present on the Co-Diagnostics earnings call?

The earnings call will feature CEO Dwight Egan and CFO Brian Brown.

Where can I access the Co-Diagnostics earnings call webcast?

The earnings call webcast can be accessed via the Events & Webcasts page on the Co-Diagnostics investor relations website.

What is the focus of Co-Diagnostics' business?

Co-Diagnostics specializes in molecular diagnostics, developing and marketing tests based on nucleic acid detection technology.